These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 1936466)

  • 1. Glucose metabolism in obesity and type 2 diabetes.
    Bonadonna RC; De Fronzo RA
    Diabete Metab; 1991 May; 17(1 Pt 2):112-35. PubMed ID: 1936466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [From obesity to diabetes or the natural history of abnormalities in the secretion and action of insulin].
    Scheen AJ
    Rev Med Liege; 1992 Jul; 47(7):325-37. PubMed ID: 1636074
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of body weight on insulin activity].
    Sindelka G; Skrha J; Prázný M; Hilgertová J
    Vnitr Lek; 1999 Sep; 45(9):540-4. PubMed ID: 10951879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus.
    Reaven GM
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():5S-12S. PubMed ID: 8299489
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetes and branched-chain amino acids: What is the link?
    Bloomgarden Z
    J Diabetes; 2018 May; 10(5):350-352. PubMed ID: 29369529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus.
    Groop LC; Saloranta C; Shank M; Bonadonna RC; Ferrannini E; DeFronzo RA
    J Clin Endocrinol Metab; 1991 Jan; 72(1):96-107. PubMed ID: 1986032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients.
    Nam SY; Kim KR; Cha BS; Song YD; Lim SK; Lee HC; Huh KB
    Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1101-7. PubMed ID: 11477493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic insulin resistance in obese non-diabetic subjects and in type 2 diabetic patients.
    Paquot N; Scheen AJ; Dirlewanger M; Lefèbvre PJ; Tappy L
    Obes Res; 2002 Mar; 10(3):129-34. PubMed ID: 11886934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exercise training in obese diabetic patients. Special considerations.
    Zierath JR; Wallberg-Henriksson H
    Sports Med; 1992 Sep; 14(3):171-89. PubMed ID: 1439393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus.
    Henry RR; Brechtel G; Griver K
    J Clin Endocrinol Metab; 1988 May; 66(5):979-86. PubMed ID: 3283164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for increased liver glycogen in patients with noninsulin-dependent diabetes mellitus after a 3-day fast.
    Clore JN; Post EP; Bailey DJ; Nestler JE; Blackard WG
    J Clin Endocrinol Metab; 1992 Mar; 74(3):660-6. PubMed ID: 1740502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between free fatty acids and glucose metabolism.
    Boden G
    Curr Opin Clin Nutr Metab Care; 2002 Sep; 5(5):545-9. PubMed ID: 12172479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of free fatty acids in the insulin resistance of non-insulin-dependent diabetes].
    Girard J
    Diabete Metab; 1995 Apr; 21(2):79-88. PubMed ID: 7621976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interrelationship between insulin secretion and action in type 2 diabetes mellitus with different degrees of obesity: evidence supporting central obesity.
    Duman BS; Turkoglu C; Gunay D; Cagatay P; Demiroglu C; Buyukdevrim AS
    Diabetes Nutr Metab; 2003 Aug; 16(4):243-50. PubMed ID: 14768774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of body fat composition and serum adiponectin levels in diabetic obesity and non-diabetic obesity.
    Kim C; Park J; Park J; Kang E; Ahn C; Cha B; Lim S; Kim K; Lee H
    Obesity (Silver Spring); 2006 Jul; 14(7):1164-71. PubMed ID: 16899797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The possible role of adipose tissue in insulin resistance and in the physiopathology of obese diabetics].
    Guy-Grand B; Bour H
    Journ Annu Diabetol Hotel Dieu; 1972; 13(0):81-92. PubMed ID: 4606004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.